• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期糖基化终末产物受体在阿尔茨海默病神经元和星形胶质细胞中的免疫组织化学分布

Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease.

作者信息

Sasaki N, Toki S, Chowei H, Saito T, Nakano N, Hayashi Y, Takeuchi M, Makita Z

机构信息

Department of Neuropsychiatry, Sapporo Medical University, South 1, West 16, Chuo-ku, 060-8543, Sapporo, Japan.

出版信息

Brain Res. 2001 Jan 12;888(2):256-262. doi: 10.1016/s0006-8993(00)03075-4.

DOI:10.1016/s0006-8993(00)03075-4
PMID:11150482
Abstract

Advanced glycation end products (AGE) and the receptor for AGE (RAGE) have been implicated in the chronic complications of diabetes mellitus (DM), and have been reported to play an important role in the pathogenesis of Alzheimer's disease (AD). In this study, we established a polyclonal anti-RAGE antibody, and examined the immunohistochemical localization of amyloid beta protein (Abeta), AGE, and RAGE in neurons and astrocytes from patients with AD and DM. Our anti-RAGE antibody recognized full-length RAGE (50 kd) and N-terminal RAGE (35 kd) in human brain tissue. Abeta-, AGE-, and RAGE-positive granules were identified in the perikaryon of hippocampal neurons (especially from CA3 and CA4) in all subjects. The distribution and staining pattern of these immunopositive granules showed good concordance with each antibody. In AD, most astrocytes contained both AGE-and RAGE-positive granules and their distribution was almost the same. Abeta-positive granules were less common, but Abeta-, AGE-, and RAGE-positive granules were colocalized in one part of a single astrocyte. In DM patients and control cases, AGE-and RAGE-positive astrocytes were very rare. These finding support the hypothesis that glycated Abeta is taken up via RAGE and is degraded through the lysosomal pathway in astrocytes. In addition to the presence of AGE, the process of AGE degradation and receptor-mediated reactions may contribute to neuronal dysfunction and promote the progression of AD.

摘要

晚期糖基化终末产物(AGE)及其受体(RAGE)与糖尿病(DM)的慢性并发症有关,并且据报道在阿尔茨海默病(AD)的发病机制中起重要作用。在本研究中,我们制备了一种抗RAGE多克隆抗体,并检测了AD和DM患者神经元和星形胶质细胞中β淀粉样蛋白(Aβ)、AGE和RAGE的免疫组织化学定位。我们的抗RAGE抗体可识别人类脑组织中的全长RAGE(50kd)和N端RAGE(35kd)。在所有受试者海马神经元(尤其是CA3和CA4区)的胞体中均鉴定出Aβ、AGE和RAGE阳性颗粒。这些免疫阳性颗粒的分布和染色模式与每种抗体显示出良好的一致性。在AD中,大多数星形胶质细胞同时含有AGE和RAGE阳性颗粒,且它们的分布几乎相同。Aβ阳性颗粒较少见,但Aβ、AGE和RAGE阳性颗粒在单个星形胶质细胞的一部分中共定位。在DM患者和对照病例中,AGE和RAGE阳性星形胶质细胞非常罕见。这些发现支持了糖化Aβ通过RAGE被摄取并在星形胶质细胞中通过溶酶体途径降解的假说。除了AGE的存在外,AGE降解过程和受体介导的反应可能导致神经元功能障碍并促进AD的进展。

相似文献

1
Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease.晚期糖基化终末产物受体在阿尔茨海默病神经元和星形胶质细胞中的免疫组织化学分布
Brain Res. 2001 Jan 12;888(2):256-262. doi: 10.1016/s0006-8993(00)03075-4.
2
Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer's disease.在阿尔茨海默病的三转基因小鼠模型中,神经元和星形胶质细胞中晚期糖基化终产物受体的表达增加。
Exp Mol Med. 2014 Feb 7;46(2):e75. doi: 10.1038/emm.2013.147.
3
Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.预防阿尔茨海默病中晚期糖基化终产物受体的激活。
Curr Drug Targets CNS Neurol Disord. 2005 Jun;4(3):249-66. doi: 10.2174/1568007054038210.
4
Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques.患有朊病毒斑块的克雅氏病患者大脑中的晚期糖基化终末产物(AGE)及其受体(RAGE)
Neurosci Lett. 2002 Jun 28;326(2):117-20. doi: 10.1016/s0304-3940(02)00310-5.
5
Reduced expression of endogenous secretory receptor for advanced glycation endproducts in hippocampal neurons of Alzheimer's disease brains.阿尔茨海默病大脑海马神经元中晚期糖基化终产物内源性分泌受体的表达降低。
Arch Histol Cytol. 2007 Dec;70(5):279-90. doi: 10.1679/aohc.70.279.
6
RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease.在阿尔茨海默病中,RAGE是β淀粉样蛋白诱导的细胞功能紊乱的关键细胞靶点。
Front Biosci (Schol Ed). 2012 Jan 1;4(1):240-50. doi: 10.2741/s265.
7
AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.衰老相关的应激:阿尔茨海默病病理和治疗的变化态势。
Mol Cell Biochem. 2019 Sep;459(1-2):95-112. doi: 10.1007/s11010-019-03553-4. Epub 2019 May 11.
8
Role of Aβ-receptor for advanced glycation endproducts interaction in oxidative stress and cytosolic phospholipase A₂ activation in astrocytes and cerebral endothelial cells.β淀粉样肽受体与晚期糖基化终产物相互作用在星形胶质细胞和脑内皮细胞氧化应激及胞质型磷脂酶 A₂激活中的作用
Neuroscience. 2011 Dec 29;199:375-85. doi: 10.1016/j.neuroscience.2011.09.038. Epub 2011 Sep 28.
9
RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease.小胶质细胞中 RAGE 依赖性信号转导导致阿尔茨海默病小鼠模型中的神经炎症、Abeta 积累和学习/记忆受损。
FASEB J. 2010 Apr;24(4):1043-55. doi: 10.1096/fj.09-139634. Epub 2009 Nov 11.
10
Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease.晚期糖基化终产物(AGEs)可能参与阿尔茨海默病的发病机制。
Curr Pharm Des. 2008;14(10):973-8. doi: 10.2174/138161208784139693.

引用本文的文献

1
Ceria-nanocluster based therapy for Alzheimer's disease through the modulation of activated microglia and attenuation of amyloid-β deposition.基于二氧化铈纳米团簇的阿尔茨海默病治疗:通过调节活化的小胶质细胞和减轻淀粉样β蛋白沉积
Cell Biomater. 2025 Aug 6. doi: 10.1016/j.celbio.2025.100158.
2
A study on appetite of overweight/obese patients with type 2 diabetes mellitus based on multimodal magnetic resonance imaging.一项基于多模态磁共振成像的2型糖尿病超重/肥胖患者食欲研究。
Front Neuroimaging. 2025 Jul 15;4:1615654. doi: 10.3389/fnimg.2025.1615654. eCollection 2025.
3
Alzheimer's Is a Multiform Disease of Sustained Neuronal Integrated Stress Response Driven by the C99 Fragment Generated Independently of AβPP; Proteolytic Production of Aβ Is Suppressed in AD-Affected Neurons: Evolution of a Theory.
阿尔茨海默病是一种由独立于淀粉样前体蛋白(AβPP)产生的C99片段驱动的持续性神经元综合应激反应的多形性疾病;在受阿尔茨海默病影响的神经元中,Aβ的蛋白水解产生受到抑制:一种理论的演变
Int J Mol Sci. 2025 Apr 29;26(9):4252. doi: 10.3390/ijms26094252.
4
Peripheral Inflammation and Insulin Resistance: Their Impact on Blood-Brain Barrier Integrity and Glia Activation in Alzheimer's Disease.外周炎症与胰岛素抵抗:它们对阿尔茨海默病中血脑屏障完整性和胶质细胞激活的影响。
Int J Mol Sci. 2025 Apr 29;26(9):4209. doi: 10.3390/ijms26094209.
5
Innate and adaptive immunity in neurodegenerative disease.神经退行性疾病中的先天性免疫和适应性免疫。
Cell Mol Life Sci. 2025 Feb 2;82(1):68. doi: 10.1007/s00018-024-05533-4.
6
Production of Amyloid-β in the Aβ-Protein-Precursor Proteolytic Pathway Is Discontinued or Severely Suppressed in Alzheimer's Disease-Affected Neurons: Contesting the 'Obvious'.在阿尔茨海默病受累神经元中,淀粉样前体蛋白水解途径中β淀粉样蛋白的产生停止或受到严重抑制:对“显而易见”的观点提出质疑。
Genes (Basel). 2025 Jan 2;16(1):46. doi: 10.3390/genes16010046.
7
Pathology of Amyloid-β (Aβ) Peptide Peripheral Clearance in Alzheimer's Disease.阿尔茨海默病中淀粉样β(Aβ)肽外周清除的病理学。
Int J Mol Sci. 2024 Oct 11;25(20):10964. doi: 10.3390/ijms252010964.
8
Quintessential Synergy: Concurrent Transient Administration of Integrated Stress Response Inhibitors and BACE1 and/or BACE2 Activators as the Optimal Therapeutic Strategy for Alzheimer's Disease.精髓协同作用:同时给予综合应激反应抑制剂和 BACE1 和/或 BACE2 激活剂,作为阿尔茨海默病的最佳治疗策略。
Int J Mol Sci. 2024 Sep 13;25(18):9913. doi: 10.3390/ijms25189913.
9
ACH2.0/E, the Consolidated Theory of Conventional and Unconventional Alzheimer's Disease: Origins, Progression, and Therapeutic Strategies.ACH2.0/E,即传统和非传统阿尔茨海默病的综合理论:起源、进展和治疗策略。
Int J Mol Sci. 2024 May 30;25(11):6036. doi: 10.3390/ijms25116036.
10
On the Inadequacy of the Current Transgenic Animal Models of Alzheimer's Disease: The Path Forward.论当前阿尔茨海默病转基因动物模型的不足:未来之路
Int J Mol Sci. 2024 Mar 4;25(5):2981. doi: 10.3390/ijms25052981.